News

Adlai Nortye prices Nasdaq IPO, raises $97.5M

The Nasdaq is welcoming another company hustling along a late-stage drug, with Adlai Nortye raising $97.5 million from an IPO and a concurrent private placement. Adlai Nortye licensed its lead program, the PI3K inhibitor buparlisib, […]

[adinserter block="3"]
News

AscellaHealth Launches Q3 2023 Specialty & Rare Pipeline Digest™: Expert Resource for FDA Approval Status of Specialty Pharmaceuticals and Cell & Gene Therapies

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth Launches Q3 2023 Specialty & Rare Pipeline Digest™: Expert Resource for FDA Approval Status of Specialty Pharmaceuticals & CGT Click here to view original post

[adinserter block="3"]
[adinserter block="3"]
News

Novel iTind Procedure Now Included in Treatment Guideline for Lower Urinary Tract Symptoms Caused by Enlarged Prostate

Temporary Implanted Prostatic Devices Added to AUA Clinical Practice Guideline CENTER VALLEY, Pa., Sept. 28, 2023 /PRNewswire/ — Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, […]